The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception

BACKGROUND AND PURPOSE: PZM21 is a novel μ‐opioid receptor ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ receptor ligands such as morphine. We have re‐examined the signalling profile of PZM21 and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Pharmacol
Main Authors: Hill, Rob, Disney, Alex, Conibear, Alex, Sutcliffe, Katy, Dewey, William, Husbands, Stephen, Bailey, Chris, Kelly, Eamonn, Henderson, Graeme
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Research Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6003631/
https://ncbi.nlm.nih.gov/pubmed/29582414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14224
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki